» Articles » PMID: 18086893

Regulation of Neuron-specific Alternative Splicing of Neurofibromatosis Type 1 Pre-mRNA

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2007 Dec 19
PMID 18086893
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Neurofibromatosis type 1 (NF1) is one of the most common heritable autosomal dominant disorders. Alternative splicing modulates the function of neurofibromin, the NF1 gene product, by inserting the in-frame exon 23a into the region of NF1 mRNA that encodes the GTPase-activating protein-related domain. This insertion, which is predominantly skipped in neurons, reduces the ability of neurofibromin to regulate Ras by 10-fold. Here, we report that the neuron-specific Hu proteins control the production of the short protein isoform by suppressing inclusion of NF1 exon 23a, while TIA-1/TIAR proteins promote inclusion of this exon. We identify two binding sites for Hu proteins, located upstream and downstream of the regulated exon, and provide biochemical evidence that Hu proteins specifically block exon definition by preventing binding of essential splicing factors. In vitro analyses using nuclear extracts show that at the downstream site, Hu proteins prevent binding of U1 and U6 snRNPs to the 5' splice site, while TIAR increases binding. Hu proteins also decrease U2AF binding at the 3' splice site located upstream of exon 23a. In addition to providing the first mechanistic insight into tissue-specific control of NF1 splicing, these studies establish a novel strategy whereby Hu proteins regulate RNA processing.

Citing Articles

Splicing to orchestrate cell fate.

Zhang X, Guo Z, Li Y, Xu Y Mol Ther Nucleic Acids. 2025; 36(1):102416.

PMID: 39811494 PMC: 11729663. DOI: 10.1016/j.omtn.2024.102416.


Post-transcriptional regulation of the transcriptional apparatus in neuronal development.

Nazim M Front Mol Neurosci. 2025; 17():1483901.

PMID: 39764514 PMC: 11701043. DOI: 10.3389/fnmol.2024.1483901.


Insights into isoform-specific mineralocorticoid receptor action in the hippocampus.

Gaudenzi C, Mifsud K, Reul J J Endocrinol. 2023; 258(2).

PMID: 37235709 PMC: 7616738. DOI: 10.1530/JOE-22-0293.


The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.

Ghram M, Morris G, Culjkovic-Kraljacic B, Mars J, Gendron P, Skrabanek L EMBO J. 2023; 42(7):e110496.

PMID: 36843541 PMC: 10068332. DOI: 10.15252/embj.2021110496.


Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases.

Silvestri B, Mochi M, Garone M, Rosa A Int J Mol Sci. 2022; 23(23).

PMID: 36498933 PMC: 9736382. DOI: 10.3390/ijms232314606.


References
1.
Zuccato E, Buratti E, Stuani C, Baralle F, Pagani F . An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem. 2004; 279(17):16980-8. DOI: 10.1074/jbc.M313439200. View

2.
Dredge B, Darnell R . Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol. 2003; 23(13):4687-700. PMC: 164843. DOI: 10.1128/MCB.23.13.4687-4700.2003. View

3.
Deschenes-Furry J, Perrone-Bizzozero N, Jasmin B . The RNA-binding protein HuD: a regulator of neuronal differentiation, maintenance and plasticity. Bioessays. 2006; 28(8):822-33. DOI: 10.1002/bies.20449. View

4.
Bourgeois C, Le Guiner C, Kister L, Gesnel M, Stevenin J, Breathnach R . The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site. Mol Cell Biol. 2000; 20(17):6287-99. PMC: 86103. DOI: 10.1128/MCB.20.17.6287-6299.2000. View

5.
Bernards A . Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs. Biochim Biophys Acta. 1995; 1242(1):43-59. DOI: 10.1016/0304-419x(95)00003-x. View